Ways Douglas Kirk bought SPRB
December 11, 2025 · Form 4 insider transaction
Ways Douglas Kirk bought 5,000 shares of Spruce Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 41 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$0.00
Total value
N/A
InsiderWays Douglas Kirk
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateDecember 11, 2025
Filing dateJanuary 21, 2026
Shares owned after5,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents a contingent right to receive one share of common stock of the Issuer.; 25% of the total number of restricted stock units ("RSUs") vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date.